MarketInOut Stock Screener Log In | Sign Up

Transgene Biotek Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/27/2026 15:50
Transgene Biotek Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization197 mln
Float50.61 mln

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-2.35
Borderline

Relative Strength

26 / 100
Underperforming

Debt / Equity

2.05
Very high leverage

Pre-Tax Margin

-725%
Severely loss-making

ROE

-48.06
Deeply negative

Business Description

Transgene Biotek Limited is an Indian biotechnology company founded in 1990 and headquartered in Sangareddy, focused on developing and manufacturing pharmaceutical ingredients and drug products. The company specializes in cancer treatments, oral drug formulations, and biosimilar medicines, serving both healthcare and nutritional markets. Its key products include an immune-suppressing drug used after organ transplants, a fat-blocking weight management compound, and a nutritional ingredient used across baby food, health supplements, and animal feed.

Key Fundamentals

EPS-0.21
ROE-48.06
RPS0.03
ROIC-0.55
ROA-1.50
Interest Cover-0.59
EBITDA, mln-3.13
EV / EBITDA-108
EV / EBIT-66.88
Revenue, mln2.22
EV / Revenue152

Quote Details

Last 2.42
Change -0.11 (-4.35%)
Open 2.53
Volume 16,041
Turnover 38,819
Average Volume 21,178

Financial Ratios

Pre-Tax Profit Margin-725
Current Ratio0.08
Price / Book2.34
Price / Tangible Book10.75
Debt / Equity2.05
Price / Sales88.96

Financial Strength

Altman Z-Score-0.04
Piotroski F-Score 1 / 9
Beneish M-Score-2.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.2% 52 / 100   
1 Month -5.1% 60 / 100   
2 Months -18.79% 23 / 100   
6 Months -15.09% 36 / 100   
1 Year -43.59% 15 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog